R.PR
REGISTERED-PRINCIPAL REGISTER
24/11/2020
Voltar para busca
Dado oficial do USPTO
RANDOX DISCOVERY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
RANDOX DISCOVERY
ST13
US500000088318383Classe
1, 5, 9, 10
Pedido
88318383
Registro
6203127
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
29
Atualização mais recente
24/11/2020
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 10
Data de depósito
27/02/2019
Data de registro
24/11/2020
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/11/2020
Última transação
24/11/2020
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Crumlin, Antrim, GB
Examinador
CIURPITA, DREW
Unidade examinadora
M50
Localização atual
PETITIONS OFFICE
Titulares e representantes
Titulares
Randox Laboratories Ltd
Randox Laboratories Ltd
Representantes
Daniel Frohling LOEB & LOEB LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Diagnostic preparations for scientific purposes; chemical reagents for scientific or medical research and for use in the analysis of food products; enzymes for use in scientific and medical research applications; protein arrays for use in scientific and medical research applications; diagnostic preparations for analysis of food products and water for scientific or research use; clinical diagnostic preparations for clinical or medical laboratory use; clinical diagnostic reagents for in vitro use for clinical or medical laboratory use; chemical reagents other than for medical or veterinary purposeschemical reagents for detection and monitoring of disease states in vitro for laboratory research purposes; diagnostic proteinsprotein arrays for scientific and medical research featuring antibodies and antigens used for monitoring of disease states in vitro
Classe 5
Diagnostic preparations and substances for medical and veterinary purposes; diagnostic kits in the nature of clinical chemistry and immunology test kits for medical use in the detection and monitoring of disease states in vitrochemical reagents for medical or veterinary purposes for the detection and monitoring of disease states including cardiacDOAstrokemetaboliccancerdiabetesfertilitythyroid and DNA arrays; clinical diagnostic preparationsfor medical or veterinary use; clinical diagnostic reagents for in vivo use for medical or veterinary purposes; diagnostic scanning agents for in vivo use for medical or veterinary purposes; diagnostic testing materials for medical use in the detection and monitoring of disease states in vitrochemical reagents for medical or veterinary purposes for the detection and monitoring of disease states including cardiacDOAstrokemetaboliccancerdiabetesfertilitythyroid and DNA arrays; medical diagnostic proteinsprotein arrays for medical diagnostic purposes featuring antibodies and antigens used for medical detection of disease states in vitro; chemical reagentschemical reagents for detection and monitoring of disease states in vitro
Classe 9
Downloadable computer software for use in conjunction with in vitro diagnostic testing apparatussoftware for controlling medical and clinical sample processingsample result reporting and test apparatus system robotics; computer hardware for or relating to the analysismonitoringresearch and/or reporting of clinical data; downloadable computer programs for use in conjunction with in vitro diagnostic testing apparatus for controlling medical and clinical sample processing and sample result reporting; computer systemscomputer hardware and downloadable software for use in conjunction with in vitro diagnostic testing apparatus for controlling medical and clinical sample processing and sample result reporting; computer systems for use in conjunction with in vitro diagnostic testing apparatusdownloadable computer software and hardware for controlling medical and clinical sample processing; downloadable computer databases and computer databases recorded on computer media for use in connection with in vitro diagnostic testing apparatusdownloadable electronic data files featuring medical diagnostic sample results; scientific and optical apparatus and instrumentsa benchtop analytical system composed of barcode scanner and associated software for reading barcodesa chemiluminescent detection system in the nature of instruments for measuring chemiluminescencea temperature controlled incubator for laboratory usean electronic reagent and patient sample dispensersuitable for protein and DNA arrays for or relating to the analysismonitoringresearch and/or reporting of clinical datafor use in vitro diagnostic testing procedures for clinicalveterinaryfood and toxicological analysis; clinical analyzers not for medical and veterinary useacidity analyzersliquid analyzersresidual gas analyzers for use in vitro diagnostic testing procedures and for use in measuring blood proteinsantibodiesenzymesimmunoglobulinshormones and drugs for laboratory use; light detectors for use in vitro diagnostic testing proceduresa chemiluminescence detection system not for medical purposes; parts and fittings for all the aforesaid goodsreplacement parts and fittings
Classe 10
Medical apparatus and instruments for medical usefor use in vitro diagnostic testing procedures to detect and diagnose drug residues used in immunoassay procedures and for use in measuring blood proteinsantibodiesenzymesimmunoglobulins and hormones; diagnostic apparatus and instruments for medical usefor use in vitro diagnostic testing procedures to detect and diagnose drug residues used in immunoassay procedures and for use in measuring blood proteinsantibodiesenzymesimmunoglobulinshormones and drugs; diagnostic imaging apparatus for medical useelectromechanical diagnostic analyser utilizing a chemiluminescent detection system for use in in vitro diagnostic testing procedures and for use in measuring blood proteinsantibodiesenzymesimmunoglobulinshormones and drugs; medical diagnostic testing apparatus and instruments for use in immunoassay proceduresfor use in the measurement of antibodiesimmunoglobulinshormones and drugs representing various drug classes; light detectors for use in vitro diagnostic testing proceduresa chemiluminescence detection system for medical purposes; clinical analyzers for medical and veterinary useacidity analyzersliquid analyzersresidual gas analyzers for use in vitro diagnostic testing procedures and for use in measuring blood proteinsantibodiesenzymesimmunoglobulinshormones and drugs
Publicações
Histórico de despachos e eventos da marca no USPTO.
29 publicações encontradas
ERTI
TEAS RESPONSE TO PETITION INQUIRY LETTER
22/10/2020
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
21/10/2020
APET
ASSIGNED TO PETITION STAFF
20/10/2020
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
14/10/2020
MAB6
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
13/10/2020
ABN6
ABANDONMENT - NO USE STATEMENT FILED
12/10/2020
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
01/09/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/03/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/01/2020
PUBO
PUBLISHED FOR OPPOSITION
14/01/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/12/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/12/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
05/12/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/12/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
05/12/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/12/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/10/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/10/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/10/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
15/05/2019
GNRT
NON-FINAL ACTION E-MAILED
15/05/2019
CNRT
NON-FINAL ACTION WRITTEN
15/05/2019
DOCK
ASSIGNED TO EXAMINER
08/05/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/03/2019
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
11/03/2019
ALIE
ASSIGNED TO LIE
11/03/2019
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
06/03/2019
NWAP
NEW APPLICATION ENTERED
02/03/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace RANDOX DISCOVERY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.